Stress Urinary Incontinence Device Market is expected to grow at an 5.5% CAGR during the forecast period for 2025-2034

Stress Urinary Incontinence (SUI) is the involuntary leakage of urine during activities that upsurge pressure inside the abdomen and push down on the bladder, such as coughing, sneezing, running, or heavy lifting. There are numerous sources of SUI which comprise pregnancy, childbirth (particularly where forceps were needed), weight gain, and chronic straining or coughing. Multiple devices such as Vaginal inserts, including incontinence pessaries and incontinence tampons are designed to prevent urinary leakage, usually for women with stress urinary incontinence (SUI).
Augmented in geriatric population, huge pool of women showing early symptoms of menopause, growing cases of hysterectomy is expected to be one of the prominent factors driving the market growth. The market is further expected to grow at a significant rate owing to features such as rising number of investments in health care, escalating awareness, and expanding number of obese populations. The cumulative occurrence of smoking in women are expected to play a key role in promoting market growth over the next few years.
The Global Stress Urinary Incontinence Device market is categorized on the basis of product, end-user and region. On the basis of product type, the market is segmented into Sling Systems, Vaginal Pessary Devices, Artificial Urinary Sphincter (AUS), Pelvic Floor Muscle Stimulator, and Injectable Urethral Bulking Agents/Injections. On the basis of end-user, the market is segmented into Hospitals, Gynecological Clinics, and Homecare Settings. Based on region, the market is studied across North America, Asia-Pacific, Europe, and LAMEA. Among all, North America is expected to dominate the market during the analysis of the forecast period.
| Report Attribute | Specifications |
| Growth Rate CAGR | CAGR of 5.5% from 2025 to 2034 |
| Quantitative Units | Representation of revenue in US$ Million, Volume (Unit), and CAGR from 2023 to 2031 |
| Historic Year | 2021 to 2024 |
| Forecast Year | 2025-2034 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Product, By End-Users |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; South Korea; South East Asia |
| Competitive Landscape | Coloplast A/S, Contura Ltd., Laborie, Inc. (Cogentix Medical), Atlantic Therapeutics, Boston Scientific Corporation, Johnson & Johnson Services. Inc., BD, CooperSurgical, Inc., MEGYN PRODUCTS, INC., Cousin Biotech, Caldera Medical, Betatech Medical, FEG Textiltechnik mbH, Affluent Medical, pfm medical ag, Betatech Medical, Caldera Medical Inc., Neomedic International, EUROMED, Zephyr Surgical Implants, and Others |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing and Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Stress Urinary Incontinence Device Market Snapshot
Chapter 4. Global Stress Urinary Incontinence Device Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Dynamics - Drivers
4.3. Challenges/Restraints
4.4. Market Trends
4.5. Industry Analysis – Porter’s Five Forces Analysis
4.6. SUI Epidemiology Analysis in Key Countries 2019
4.7. COVID 19 Impact on Medical Device Industry 2020
Chapter 5. Market Segmentation 1: Product Type Estimates & Trend Analysis
5.1. Product Type & Market Share, 2024 & 2034
5.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2021 to 2034 for the following Product Type:
5.2.1. Sling Systems
5.2.2. Vaginal Pessary Devices
5.2.3. Artificial Urinary Sphincter (AUS)
5.2.4. Pelvic Floor Muscle Stimulator
5.2.5. Injectable Urethral Bulking Agents/Injections
Chapter 6. Stress Urinary Incontinence Device Market Segmentation 2: End-user Estimates & Trend Analysis
6.1. End-user Analysis & Market Share, 2024 & 2034
6.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2021 to 2034 for the following End-user:
6.2.1. Hospitals
6.2.2. Gynecological Clinics
6.2.3. Homecare Settings
Chapter 7. Stress Urinary Incontinence Device Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Stress Urinary Incontinence Device Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Product Type, 2021-2034
7.1.2. North America Stress Urinary Incontinence Device Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by End-user, 2021-2034
7.1.3. North America Stress Urinary Incontinence Device Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by country, 2021-2034
7.1.3.1. U.S.
7.1.3.2. Canada
7.2. Europe
7.2.1. Europe Stress Urinary Incontinence Device Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Product Type, 2021-2034
7.2.2. Europe Stress Urinary Incontinence Device Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by End-user, 2021-2034
7.2.3. Europe Stress Urinary Incontinence Device Market revenue (US$ Million) and volume (No. of Units) by country, 2021-2034
7.2.3.1. Germany
7.2.3.2. Poland
7.2.3.3. France
7.2.3.4. Italy
7.2.3.5. Spain
7.2.3.6. UK
7.2.3.7. Rest of Europe
7.3. Asia Pacific
7.3.1. Asia Pacific Stress Urinary Incontinence Device Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Product Type, 2021-2034
7.3.2. Asia Pacific Stress Urinary Incontinence Device Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by End-user, 2021-2034
7.3.3. Asia Pacific Stress Urinary Incontinence Device Market revenue (US$ Million) and volume (No. of Units) by country, 2021-2034
7.3.3.1. China
7.3.3.2. India
7.3.3.3. Japan
7.3.3.4. Australia
7.3.3.5. Rest of Asia Pacific
7.4. Latin America
7.4.1. Latin America Stress Urinary Incontinence Device Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Product Type, 2021-2034
7.4.2. Latin America Stress Urinary Incontinence Device Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by End-user, 2021-2034
7.4.3. Latin America Stress Urinary Incontinence Device Market revenue (US$ Million) and volume (No. of Units) by country, (US$ Million) 2021-2034
7.4.3.1. Brazil
7.4.3.2. Rest of Latin America
7.5. MEA
7.5.1. MEA Stress Urinary Incontinence Device Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Product Type, 2021-2034
7.5.2. MEA Stress Urinary Incontinence Device Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by End-user, 2021-2034
7.5.3. MEA revenue Stress Urinary Incontinence Device Market revenue (US$ Million) and volume (No. of Units) by country, (US$ Million) 2021-2034
7.5.3.1. South Africa
7.5.3.2. Rest of MEA
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Coloplast A/S
8.2.1.1. Company Overview
8.2.1.2. Financials
8.2.1.3. Product portfolio
8.2.1.4. Business strategy & Recent developments
8.2.2. Contura Ltd.
8.2.3. Elidah, Inc.
8.2.4. Laborie, Inc. (Cogentix Medical)
8.2.5. Atlantic Therapeutic
8.2.6. Boston Scientific Corporation,
8.2.7. Johnson & Johnson Services. Inc.
8.2.8. BD
8.2.9. CooperSurgical, Inc.
8.2.10. MEDGYN PRODUCTS, INC.
8.2.11. Cousin Biotech
8.2.12. Caldera Medical
8.2.13. Betatech Medical
8.2.14. FEG Textiltechnik mbH.
8.2.15. Affluent Medical
8.2.16. pfm medical ag
8.2.17. Betatech Medical
8.2.18. Caldera Medical Inc
8.2.19. Neomedic International
8.2.20. UROMED
8.2.21. Zephyr Surgical Implants
8.2.22. Viveve Medical, Inc.
8.2.23. UroMems
8.3. List of Other Prominent Players
Global Stress Urinary Incontinence Device Market Based on Product
Global Stress Urinary Incontinence Device Market Based on End user
Global Stress Urinary Incontinence Device Market Based on Region
Europe
North America
Asia Pacific
Latin America
Middle East & Africa